DACH.F Stock Overview
Engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.52 |
| 52 Week High | JP¥8.52 |
| 52 Week Low | JP¥7.80 |
| Beta | 0.65 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| DACH.F | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | 0.3% |
| 1Y | n/a | 11.4% | 31.1% |
Return vs Industry: Insufficient data to determine how DACH.F performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how DACH.F performed against the US Market.
Price Volatility
| DACH.F volatility | |
|---|---|
| DACH.F Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DACH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DACH.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,207 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| DACH.F fundamental statistics | |
|---|---|
| Market cap | US$2.57b |
| Earnings (TTM) | US$337.42m |
| Revenue (TTM) | US$3.80b |
7.6x
P/E Ratio0.7x
P/S RatioIs DACH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DACH.F income statement (TTM) | |
|---|---|
| Revenue | JP¥542.80b |
| Cost of Revenue | JP¥398.14b |
| Gross Profit | JP¥144.66b |
| Other Expenses | JP¥96.44b |
| Earnings | JP¥48.22b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 06, 2024
| Earnings per share (EPS) | 172.25 |
| Gross Margin | 26.65% |
| Net Profit Margin | 8.88% |
| Debt/Equity Ratio | 84.4% |
How did DACH.F perform over the long term?
See historical performance and comparison